Rifaximin versus Placebo Preventing the Recurrence of Clinically Overt Hepatic Encephalopathy in Patients having Cirrhosis of Liver. (2024). Medical Forum Monthly, 28(12). https://medicalforummonthly.com/index.php/mfm/article/view/4304